Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis

Background: Although with the application of etanercept biosimilars in the field of rheumatoid arthritis, the evidences of their efficacy, safety, and immunogenicity are still limited. We conducted this meta-analysis to evaluate the efficacy, safety and immunogenicity of etanercept biosimilars for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Rui, Yuan, Tao, Wang, Hui, Zhao, Jianglin, Shi, Liya, Li, Quankai, Zhu, Chunmei, Su, Na, Zhang, Shengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979087/
https://www.ncbi.nlm.nih.gov/pubmed/36874005
http://dx.doi.org/10.3389/fphar.2023.1089272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979087/
https://www.ncbi.nlm.nih.gov/pubmed/36874005
http://dx.doi.org/10.3389/fphar.2023.1089272

Ejemplares similares